Properties of Glass Ionomer Cements Associated With Chlorhexidine or Doxycycline
Biological and Physicomechanical Properties of Glass Ionomer Cements Associated With Chlorhexidine or Doxycycline
2 other identifiers
interventional
18
0 countries
N/A
Brief Summary
This study assessed the clinical performance of a resin-modified glass ionomer cement containing different concentrations of chlorhexidine digluconate and doxycycline hyclate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Mar 2008
Typical duration for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 3, 2014
CompletedFirst Posted
Study publicly available on registry
June 20, 2014
CompletedJune 23, 2014
June 1, 2014
2 years
June 3, 2014
June 19, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Indirect Pulp Treatment using GIC associated with 1.25% CHX or 4.5% DOX.
Within 3 months after the initial treatment, the teeth were submitted to clinical and radiographic examination to determine signs and symptoms of pulp vitality.
up to 3 months
Secondary Outcomes (1)
Indirect Pulp Treatment using GIC associated with 1.25% CHX or 4.5% DOX.
up to 3 months
Study Arms (3)
Chlorhexidine - CHX
EXPERIMENTALDeciduous teeth were filled with GIC containing 1.25% chlorhexidine.
Doxycycline - DOX
EXPERIMENTALDeciduous teeth were filled with GIC containing 4.5% doxycycline.
Glass ionomer cement - GIC
PLACEBO COMPARATORDeciduous teeth were filled with GIC without chlorhexidine or doxycycline.
Interventions
Carious dentine was sampled from the mesial portion of the cavity floor and the pulpal wall was entirely covered with one of the randomly selected materials: GIC containing 4.5% DOX; GIC containing 1.25% CHX or GIC as a control group. The antimicrobial concentrations were chosen based in the previous in vitro results obtained in this study. The cavities were then temporarily restored using a conventional GIC. Within 3 months after the initial treatment,the materials were carefully and completely removed, a new dentine sample was collected, and the teeth were then restored with a light-cured composite resin using a bonding system, after a new placement of the initial liner material.
Eligibility Criteria
You may qualify if:
- an active deep carious lesion at the internal half of the dentine thickness of a primary molar that had not been previously restored and that involved the occlusal or occlusoproximal surface;
- the absence of signs of irreversible damage to the pulp
- the absence of radiolucencies at the interradicular or periapical region or thickening of the periodontal spaces, absence of internal and external root resorption, absence of calcification of the pulp tissue
- children presenting no systemic disease or those not using medications.
You may not qualify if:
- presence of signs of irreversible damage to the pulp
- children presenting systemic disease or those using medications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
de Castilho AR, Duque C, Negrini Tde C, Sacono NT, de Paula AB, de Souza Costa CA, Spolidorio DM, Puppin-Rontani RM. In vitro and in vivo investigation of the biological and mechanical behaviour of resin-modified glass-ionomer cement containing chlorhexidine. J Dent. 2013 Feb;41(2):155-63. doi: 10.1016/j.jdent.2012.10.014. Epub 2012 Oct 30.
PMID: 23123495RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aline RF Castilho, PhD
Piracicaba Dental School, Unicamp
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
June 3, 2014
First Posted
June 20, 2014
Study Start
March 1, 2008
Primary Completion
March 1, 2010
Study Completion
October 1, 2011
Last Updated
June 23, 2014
Record last verified: 2014-06